Frontline: Better Bones, the osteoporosis workshop, is presented by a distinguished panel of experts who specialize in the field of bone treatment, research, health promotion and disease prevention.
Marjorie Luckey, MD is Associate Professor of Reproductive Science at Mount Sinai Medical Center in New York, NY and is Medical Director of the Osteoporosis and Metabolic Bone Disease Center at the Saint Barnabas Heath Care System in Livingston, NJ. She holds Board Certifications in both Internal Medicine and in Endocrinology and Metabolism.
Dr. Luckey is a nationally recognized expert in the field of osteoporosis and metabolic bone disease and has been actively engaged in bone disease research, education and patient care since 1982. Her independent research and publications have included NIH supported studies of bone health and calcium metabolism in African-American women; studies on the effects of organ transplantation, genetic diseases and primary biliary cirrhosis on bone health and investigations into the appropriateness of laboratory testing in osteoporotic women. In addition she has participated in many multi-national trials of new therapeutic agents for osteoporosis.
On a national level, she has served on the Scientific Advisory Board of the National Osteoporosis Foundation; Professional Practice Committee, Program Committees and Adult Bone and Mineral Working Group of the American Society of Bone and Mineral Research; the National Bone Health Campaign Scientific Task Force for the CDC ; Scientific Advisory Board, Certification Committee and faculty of International Society for Clinical Densitometry; the Research Advisory Council of the National Osteoporosis Business Coalition; and as an ad hoc reviewer for the NIH. She also currently serves on the Editorial Board of the Journal of Clinical Densitometry. Locally, she is co-chair of the Metropolitan Bone Club in NYC and serves on the Scientific Advisory Committee and the Legislative Advisory Board of the NJ Inter-Agency Council on Osteoporosis.
Dr. Bilezikian, Professor of Medicine and Pharmacology at the College of Physicians & Surgeons, Columbia University is Chief of the Division of Endocrinology and Director of the Metabolic Bone Diseases Program at Columbia-Presbyterian Medical Center. He also serves as Associate Chair, Department of Medicine. Dr. Bilezikian received his undergraduate training at Harvard College and his medical training at the College of Physicians & Surgeons. He completed four years of house staff training (internship and residency) including the Chief Medical Residency of the Medical Service at Columbia Presbyterian Medical Center. Dr. Bilezikian received his training in Metabolic Bone Diseases and in Endocrinology at the NIH where he served as a Clinical Associate in the Mineral Metabolism Branch under the tutelage of Dr. Gerald Aurbach. Dr. Bilezikian belongs to a number of professional societies including the American Society for Bone and Mineral Research, of which he served as President in 1996 and the International Society of Clinical Densitometry, of which he served as President, 1999-2001. He is a member of the Endocrine Society, the American Federation for Clinical Research, the American Society for Clinical Investigation, the Association of American Physicians, the American Association of Clinical Endocrinologists, the American Society for Pharmacology and Experimental Therapeutics, and the American College of Endocrinology which has designated him Master. He is Editor-in-Chief of the Journal of Clinical Endocrinology and Metabolism. His books include Editor-in-Chief of The Parathyroids (1994, 2001), and co-editor of Principles of Bone Biology (1996, 2002), The Aging Skeleton (1999), and Dynamics of Bone and Cartilage Metabolism (1999). He has been on numerous panels, including serving as Chair of the NIH Consensus Development Panel on Optimal Calcium Intake, and the Food and Nutrition Board of the National Academy of Sciences. He is a major national and international spokesperson for the field of metabolic bone diseases. Dr. Bilezikian's major research interests are related to the clinical investigation of metabolic bone diseases, particularly osteoporosis and primary hyperparathyroidism. He is the recipient of the Distinguished Physician Award of the Endocrine Society and of the Frederic C. Bartter Award of the American Society for Bone and Mineral Research for Excellence in Clinical Research. He also has an active laboratory program in the biochemical mechanisms of the hormones that regulate calcium metabolism. His publications, which number over 400, speak to his active original investigative initiatives as well as his demand as an author of many reference sources of endocrinology and metabolic bone diseases.
Dr. Susan Greenspan received her undergraduate degree from Stanford University and her MD from Harvard Medical School. She was trained in Endocrinology and Geriatrics at Harvard Medical School. In 1999, she moved from Boston to Pittsburgh to become Professor of Medicine at the University of Pittsburgh and Director of the Osteoporosis Prevention and Treatment Center at the University of Pittsburgh. She is also Associate Program Director of the General Clinical Research Center at University of Pittsburgh. Her NIH-funded research centers on osteoporosis in elderly women and men, and has included such topics as new therapies for osteoporosis; new ways to diagnose, assess, and monitor bone loss; bone loss in men with prostate cancer on androgen deprivation therapy; and the importance of falls in the etiology of hip fractures. Dr. Greenspan serves on the Scientific Advisory Board for the National Osteoporosis Foundation, the International Society for Clinical Densitometry, and the American Federation for Aging Research. She has been a faculty instructor for the International Society for Clinical Densitometry since 1997 and became a trustee in 2002. She serves on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Endocrinology and Metabolism. Dr. Greenspan has been an active member of the American Society for Bone and Mineral Research since 1990, and became a Council Member in 2002.
Dr. Harris is a board-certified internist and endocrinologist with a subspecialty focus on osteoporosis, metabolic bone disease and disorders of mineral metabolism. Since 1983, he has been a member of the medical school faculty at the University of California, San Francisco, where he is a Clinical Professor of Medicine and Radiology. Dr. Harris serves as chief of the osteoporosis clinic and maintains an active consultative practice in metabolic bone disease. He is also involved daily in a variety of clinical research projects to examine the effects of nutrition, calcium supplements, vitamin D, hormone replacement therapy, bisphosphonates, calcitonin, SERM’s and PTH upon the prevention and treatment of osteoporosis.
Dr. McClung is a clinician, educator and clinical investigator in the field of osteoporosis and metabolic bone disease. He is a board-certified endocrinologist with a special interest in disorders of skeletal and mineral metabolism. He completed his medical training at Southwestern Medical School in Dallas, his endocrinology fellowship at the National Institutes of Health and is a Fellow in the American College of Endocrinology. As founding Director of the Oregon Osteoporosis Center in Portland, Oregon, he coordinates a multi-disciplinary center for the evaluation and management of osteoporosis and other metabolic bone disorders. His Center has been a major participant in many clinical trials evaluating the use of new diagnostic devices and new treatments for osteoporosis and other bone diseases.
Dr. McClung edits a national osteoporosis newsletter and serves on the Scientific Advisory Board of the National Osteoporosis Foundation and the Council of Scientific Advisors for the International Osteoporosis Foundation. He recently received the prestigious Eli Lilly Award from the North American Menopause Society for his contributions to and innovations in the field of osteoporosis. He also serves as Assistant Director of the Department of Medical Education at Portland Providence Medical Center, and is an Associate Professor of Medicine at Oregon Health Sciences University.
Nelson B. Watts, MD is Professor of Medicine at University of Cincinnati College of Medicine and Director of the University of Cincinnati Bone Health and Osteoporosis Center. He received his medical degree from University of North Carolina School of Medicine in Chapel Hill, completed a medical internship at the Medical College of Georgia, a residency in internal medicine at Carolinas Medical Center, and a fellowship in endocrinology at the University of North Carolina. He is certified by the American Board of Internal Medicine in internal medicine and the subspecialty of endocrinology and metabolism. His major research interest is in osteoporosis, particularly the study of therapeutic agents and tests for diagnosis and monitoring. He is President of the American College of Endocrinology and Immediate Past President of the International Society of Clinical Densitometry, and is active in other professional societies. He has published more than 50 books and book chapters and more than 250 abstracts and articles in such journals as Journal of the American Medical Association and the New England Journal of Medicine.
Marjorie Luckey, MD is Associate Professor of Reproductive Science at Mount Sinai Medical Center in New York, NY and is Medical Director of the Osteoporosis and Metabolic Bone Disease Center at the Saint Barnabas Heath Care System in Livingston, NJ. She holds Board Certifications in both Internal Medicine and in Endocrinology and Metabolism.
Dr. Bilezikian, Professor of Medicine and Pharmacology at the College of Physicians & Surgeons, Columbia University is Chief of the Division of Endocrinology and Director of the Metabolic Bone Diseases Program at Columbia-Presbyterian Medical Center. He also serves as Associate Chair, Department of Medicine. Dr. Bilezikian received his undergraduate training at Harvard College and his medical training at the College of Physicians & Surgeons. He completed four years of house staff training (internship and residency) including the Chief Medical Residency of the Medical Service at Columbia Presbyterian Medical Center. Dr. Bilezikian received his training in Metabolic Bone Diseases and in Endocrinology at the NIH where he served as a Clinical Associate in the Mineral Metabolism Branch under the tutelage of Dr. Gerald Aurbach. Dr. Bilezikian belongs to a number of professional societies including the American Society for Bone and Mineral Research, of which he served as President in 1996 and the International Society of Clinical Densitometry, of which he served as President, 1999-2001. He is a member of the Endocrine Society, the American Federation for Clinical Research, the American Society for Clinical Investigation, the Association of American Physicians, the American Association of Clinical Endocrinologists, the American Society for Pharmacology and Experimental Therapeutics, and the American College of Endocrinology which has designated him Master. He is Editor-in-Chief of the Journal of Clinical Endocrinology and Metabolism. His books include Editor-in-Chief of The Parathyroids (1994, 2001), and co-editor of Principles of Bone Biology (1996, 2002), The Aging Skeleton (1999), and Dynamics of Bone and Cartilage Metabolism (1999). He has been on numerous panels, including serving as Chair of the NIH Consensus Development Panel on Optimal Calcium Intake, and the Food and Nutrition Board of the National Academy of Sciences. He is a major national and international spokesperson for the field of metabolic bone diseases. Dr. Bilezikian's major research interests are related to the clinical investigation of metabolic bone diseases, particularly osteoporosis and primary hyperparathyroidism. He is the recipient of the Distinguished Physician Award of the Endocrine Society and of the Frederic C. Bartter Award of the American Society for Bone and Mineral Research for Excellence in Clinical Research. He also has an active laboratory program in the biochemical mechanisms of the hormones that regulate calcium metabolism. His publications, which number over 400, speak to his active original investigative initiatives as well as his demand as an author of many reference sources of endocrinology and metabolic bone diseases.
Dr. Susan Greenspan received her undergraduate degree from Stanford University and her MD from Harvard Medical School. She was trained in Endocrinology and Geriatrics at Harvard Medical School. In 1999, she moved from Boston to Pittsburgh to become Professor of Medicine at the University of Pittsburgh and Director of the Osteoporosis Prevention and Treatment Center at the University of Pittsburgh. She is also Associate Program Director of the General Clinical Research Center at University of Pittsburgh. Her NIH-funded research centers on osteoporosis in elderly women and men, and has included such topics as new therapies for osteoporosis; new ways to diagnose, assess, and monitor bone loss; bone loss in men with prostate cancer on androgen deprivation therapy; and the importance of falls in the etiology of hip fractures. Dr. Greenspan serves on the Scientific Advisory Board for the National Osteoporosis Foundation, the International Society for Clinical Densitometry, and the American Federation for Aging Research. She has been a faculty instructor for the International Society for Clinical Densitometry since 1997 and became a trustee in 2002. She serves on the editorial boards of the Journal of Bone and Mineral Research and the Journal of Clinical Endocrinology and Metabolism. Dr. Greenspan has been an active member of the American Society for Bone and Mineral Research since 1990, and became a Council Member in 2002.
Dr. Harris is a board-certified internist and endocrinologist with a subspecialty focus on osteoporosis, metabolic bone disease and disorders of mineral metabolism. Since 1983, he has been a member of the medical school faculty at the University of California, San Francisco, where he is a Clinical Professor of Medicine and Radiology. Dr. Harris serves as chief of the osteoporosis clinic and maintains an active consultative practice in metabolic bone disease. He is also involved daily in a variety of clinical research projects to examine the effects of nutrition, calcium supplements, vitamin D, hormone replacement therapy, bisphosphonates, calcitonin, SERM’s and PTH upon the prevention and treatment of osteoporosis.
Dr. McClung is a clinician, educator and clinical investigator in the field of osteoporosis and metabolic bone disease. He is a board-certified endocrinologist with a special interest in disorders of skeletal and mineral metabolism. He completed his medical training at Southwestern Medical School in Dallas, his endocrinology fellowship at the National Institutes of Health and is a Fellow in the American College of Endocrinology. As founding Director of the Oregon Osteoporosis Center in Portland, Oregon, he coordinates a multi-disciplinary center for the evaluation and management of osteoporosis and other metabolic bone disorders. His Center has been a major participant in many clinical trials evaluating the use of new diagnostic devices and new treatments for osteoporosis and other bone diseases.
Dr. McClung edits a national osteoporosis newsletter and serves on the Scientific Advisory Board of the National Osteoporosis Foundation and the Council of Scientific Advisors for the International Osteoporosis Foundation. He recently received the prestigious Eli Lilly Award from the North American Menopause Society for his contributions to and innovations in the field of osteoporosis. He also serves as Assistant Director of the Department of Medical Education at Portland Providence Medical Center, and is an Associate Professor of Medicine at Oregon Health Sciences University.
Nelson B. Watts, MD is Professor of Medicine at University of Cincinnati College of Medicine and Director of the University of Cincinnati Bone Health and Osteoporosis Center. He received his medical degree from University of North Carolina School of Medicine in Chapel Hill, completed a medical internship at the Medical College of Georgia, a residency in internal medicine at Carolinas Medical Center, and a fellowship in endocrinology at the University of North Carolina. He is certified by the American Board of Internal Medicine in internal medicine and the subspecialty of endocrinology and metabolism. His major research interest is in osteoporosis, particularly the study of therapeutic agents and tests for diagnosis and monitoring. He is President of the American College of Endocrinology and Immediate Past President of the International Society of Clinical Densitometry, and is active in other professional societies. He has published more than 50 books and book chapters and more than 250 abstracts and articles in such journals as Journal of the American Medical Association and the New England Journal of Medicine.
